ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 20th, 2014 • Amarantus Bioscience Holdings, Inc. • Pharmaceutical preparations • California
This ASSET PURCHASE AGREEMENT (this “Agreement”) is entered into as of May 1, 2014 (the “Effective Date”) by and between Amarantus Bioscience Holdings Inc., a Nevada corporation, with an office at 953 Indiana Street, San Francisco, CA 94107 (“Purchaser”) and Provista Diagnostics, Inc., a Delaware corporation, with an office at 17301 N. Perimeter Drive, Suite 100, Scottsdale, AZ 85255 (“Seller”). Purchaser and Seller may be referred to hereinafter, individually as “Party” and, collectively, as the “Parties.”
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 20th, 2014 • Amarantus Bioscience Holdings, Inc. • Pharmaceutical preparations • California
This Asset Purchase Agreement (“Agreement”), dated as of April 29, 2014 (the “Effective Date”), is entered into by and between Memory Dx, LLC, an Arizona limited liability company (“MDx”), and Amarantus Bioscience Holdings Inc., a Nevada corporation (“Amarantus”).
